Preoperative Fibrinogen Albumin Ratio is an Effective Biomarker for Prognostic Evaluation of Gallbladder Carcinoma After Radical Resection: A 10-Year Retrospective Study at a Single Center

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol. 2014;6:99–109. doi:10.2147/CLEP.S37357
   PubMed Web of Science ®Google Scholar
• Huang J, Patel HK, Boakye D, et al. Worldwide distribution, associated factors, and trends of gallbladder cancer: a global country-level analysis. Cancer Lett. 2021;521:238–251. doi:10.1016/j.canlet.2021.09.004
   Web of Science ®Google Scholar
• Lindnér P, Holmberg E, Hafström L. Gallbladder cancer - no improvement in survival over time in a Swedish population. Acta Oncol. 2018;57(11):1482–1489. doi:10.1080/0284186X.2018.1478124
   PubMed Web of Science ®Google Scholar
• Munn LL. Cancer and inflammation. Wiley Interdiscip Rev Syst Biol Med. 2017;9(2):10. doi:10.1002/wsbm.1370
   Web of Science ®Google Scholar
• Binnewies M, Roberts EW, Kersten K, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24(5):541–550. doi:10.1038/s41591-018-0014-x
   PubMed Web of Science ®Google Scholar
• Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019;51(1):27–41. doi:10.1016/j.immuni.2019.06.025
   PubMed Web of Science ®Google Scholar
• Li L, Ren T, Liu K, et al. Development and validation of a prognostic nomogram based on the systemic immune-inflammation index for resectable gallbladder cancer to predict survival and chemotherapy benefit. Front Oncol. 2021;11:692647. doi:10.3389/fonc.2021.692647
   Web of Science ®Google Scholar
• Sun L, Hu W, Liu M, et al. High systemic inflammation response index (SIRI) indicates poor outcome in gallbladder cancer patients with surgical resection: a single institution experience in China. Cancer Res Treat. 2020;52(4):1199–1210. doi:10.4143/crt.2020.303
   PubMed Web of Science ®Google Scholar
• Cao P, Hong H, Yu Z, et al. A novel clinically prognostic stratification based on prognostic nutritional index status and histological grade in patients with gallbladder cancer after radical surgery. Front Nutr. 2022;9:850971. doi:10.3389/fnut.2022.850971
   Web of Science ®Google Scholar
• Wang J, Bo X, Li M, et al. Prediction efficacy for clinical outcome of prognostic nutritional index in patients with resectable biliary tract cancer depends on sex and obstructive jaundice status. Ann Surg Oncol. 2021;28(1):430–438. doi:10.1245/s10434-020-08728-8
   Web of Science ®Google Scholar
• Li C, Peng W, Zhang X-Y, et al. The preoperative platelet to albumin ratio predicts the prognosis of hepatocellular carcinoma patients without portal hypertension after liver resection. Medicine. 2019;98(45):e17920. doi:10.1097/MD.0000000000017920
   Web of Science ®Google Scholar
• Xu WY, Zhang HH, Xiong JP, et al. Prognostic significance of the fibrinogen-to-albumin ratio in gallbladder cancer patients. World J Gastroenterol. 2018;24(29):3281–3292. doi:10.3748/wjg.v24.i29.3281
   PubMed Web of Science ®Google Scholar
• Sun L, Ke X, Wang D, et al. Prognostic value of the albumin-to-γ-glutamyltransferase ratio for gallbladder cancer patients and establishing a nomogram for overall survival. J Cancer. 2021;12(14):4172–4182. doi:10.7150/jca.49242
   Web of Science ®Google Scholar
• Li H, Li J, Wang J, et al. Assessment of liver function for evaluation of long-term outcomes of intrahepatic cholangiocarcinoma: a multi-institutional analysis of 620 patients. Front Oncol. 2020;10:525. doi:10.3389/fonc.2020.00525
   PubMed Web of Science ®Google Scholar
• Jabłońska E, Kiluk M, Markiewicz W, et al. TNF-alpha, IL-6 and their soluble receptor serum levels and secretion by neutrophils in cancer patients. Arch Immunol Ther Exp. 2001;49(1):63–69.
   PubMed Web of Science ®Google Scholar
• Treffers LW, Hiemstra IH, Kuijpers TW, et al. Neutrophils in cancer. Immunol Rev. 2016;273(1):312–328. doi:10.1111/imr.12444
   PubMed Web of Science ®Google Scholar
• Szebeni GJ, Vizler C, Kitajka K, et al. Inflammation and cancer: extra- and intracellular determinants of tumor-associated macrophages as tumor promoters. Mediators Inflamm. 2017;2017:9294018. doi:10.1155/2017/9294018
   PubMed Web of Science ®Google Scholar
• Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity. 2004;21(2):137–148. doi:10.1016/j.immuni.2004.07.017
   PubMed Web of Science ®Google Scholar
• Nojiri S, Joh T. Albumin suppresses human hepatocellular carcinoma proliferation and the cell cycle. Int J Mol Sci. 2014;15(3):5163–5174. doi:10.3390/ijms15035163
   PubMed Web of Science ®Google Scholar
• Taverna M, Marie AL, Mira JP, et al. Specific antioxidant properties of human serum albumin. Ann Intensive Care. 2013;3(1):4. doi:10.1186/2110-5820-3-4
   PubMed Web of Science ®Google Scholar
• Sahni A, Simpson-Haidaris PJ, Sahni SK, et al. Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2 (FGF-2). J Thromb Haemost. 2008;6(1):176–183. doi:10.1111/j.1538-7836.2007.02808.x
   PubMed Web of Science ®Google Scholar
• Zheng S, Shen J, Jiao Y, et al. Platelets and fibrinogen facilitate each other in protecting tumor cells from natural killer cytotoxicity. Cancer Sci. 2009;100(5):859–865. doi:10.1111/j.1349-7006.2009.01115.x
   PubMed Web of Science ®Google Scholar
• Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci. 2001;38(4):263–355. doi:10.1080/20014091084227
   PubMed Web of Science ®Google Scholar
• Kunutsor SK, Apekey TA, Van Hemelrijck M, et al. Gamma glutamyltransferase, alanine aminotransferase and risk of cancer: systematic review and meta-analysis. Int J Cancer. 2015;136(5):1162–1170. doi:10.1002/ijc.29084
   Web of Science ®Google Scholar
• Kattan MW, Scardino PT. Evidence for the usefulness of nomograms. Nat Clin Pract Urol. 2007;4(12):638–639. doi:10.1038/ncpuro0968
   PubMedGoogle Scholar
• Wang Y, Li J, Xia Y, et al. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol. 2013;31(9):1188–1195. doi:10.1200/JCO.2012.41.5984
   PubMed Web of Science ®Google Scholar
• Li Q, Chen C, Zhang J, et al. Prediction efficacy of prognostic nutritional index and albumin-bilirubin grade in patients with intrahepatic cholangiocarcinoma after radical resection: a multi-institutional analysis of 535 Patients. Front Oncol. 2021;11:769696. doi:10.3389/fonc.2021.769696
   Web of Science ®Google Scholar
• Li Q, Zhang J, Chen C, et al. A nomogram model to predict early recurrence of patients with intrahepatic cholangiocarcinoma for adjuvant chemotherapy guidance: a multi-Institutional analysis. Front Oncol. 2022;12:896764. doi:10.3389/fonc.2022.896764
   Web of Science ®Google Scholar
• Yang J, Song X, Lai Y, et al. Development and validation of a postoperative nomogram for predicting overall survival after endoscopic surgical management of olfactory neuroblastoma. EClinicalMedicine. 2020;29–30:100577. doi:10.1016/j.eclinm.2020.100577
   Google Scholar
• Ma Z, Dong F, Li Z, et al. A novel prognostic nomogram for gallbladder cancer after surgical resection: a single-center experience. J Oncol. 2021;2021:6619149. doi:10.1155/2021/6619149
   Web of Science ®Google Scholar